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ABSTRACT
Tension pneumothorax is a life-threatening
medical emergency mostly associated with
chest trauma. It is considered a leading cause
of death due to injury and represents a
substantial portion of potentially
preventable deaths in the battlefield. The
accepted therapeutic approach is manual
thoracostomy with chest tube insertion. This
is a relatively simple procedure when performed
by skilled hands and in optimal conditions. In
the battlefield and in other pre-hospital settings
or when performed by unprofessional
personnel, it may become complicated and
time-consuming. We describe a novel
technique for the treatment of pneumothorax
in the pre-hospital setting, utilizing a quick,
one-handed, easy-to-apply approach.
Keywords: Chest tube; Device; Pneumothorax;
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INTRODUCTION
Chest tubes are indwelling catheters placed into
the pleural space to evacuate abnormal
collections of air or fluids that always
represent chest pathology. The most frequent
indications for tube thoracostomy are
pneumothorax, pleural effusion, chylothorax,
empyema, trauma, and postsurgical
management after pulmonary and/or cardiac
surgery [1]. Although there is a wide variety of
chest tubes available on the market, they all
share a common mechanism of operation: (1) a
skin incision is made; (2) a tract in the
subcutaneous tissue is bluntly dissected; (3)
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the tract is manually extended to enable
insertion of the chest tube; (4) the chest tube
is then advanced through and into the thoracic
cavity; (5) the tube is then connected to a
drainage device and secured with stitches [2].
Trauma is the leading cause of death among
Americans between ages 1 and 46 years and the
third cause of death overall [3]. It is estimated
that thoracic trauma accounts for about
20–25% of all deaths resulting from trauma
[4], with tension pneumothorax occurring in
approximately 1 of 20 major trauma patients,
although estimates of its incidence vary widely
from\1 to 30 % [5]. In out-of-hospital settings,
needle decompression often appears to be an
effective, easy-to-use and relatively safe method
to treat tension pneumothorax; however, it is
only a temporary strategy as occlusion may
occur secondary to blood, particulate matter,
kinking or tissue entrapment [5, 6]. Chest tube
placement is currently the definitive treatment
for traumatic pneumothorax, but this
technique is more time-consuming than other
methods and requires trained personnel as well
as a controlled setting in order to be safely
applied. We describe here an experimental
novel technique for chest tube placement.




Thedevicewas developed to allow theplacement
of a chest tube in a quick, one-handed,
easy-to-apply manner. The device includes two
plates that are connected by hinges so that there
are two configurations—a closed figuration
(Fig. 1a) and an open configuration (Fig. 1b).
After a small incision is made in the skin, the
operator uses the device to bluntly dissect
through the subcutaneous tissue until the
pleural space is reached (Fig. 2a). After
penetration, the device is activated, and a
configuration change occurs, from closed to
open (Fig. 2b). In its open configuration a portal
is created, through which a standard silicon tube
is inserted for proper drainage (Fig. 2c). After the
chest tube is positioned, the device is removed,
leaving the chest tube in place (Fig. 2d).
Experimental Model
An in vivo pilot experiment on a swine model
to establish a proof-of-concept was successfully
carried out (Fig. 3). We used the porcine model
to simulate chest drain placement using the
ThoraXS device. We first performed a 1-cm
incision in the chest wall, then inserted the
device in its closed configuration through the
incision. Once positioned in the pleural space,
the device was activated, easily expanding
inside the chest wall tissue, and a 20 Fr
silicone tube was inserted into the pleural
space. This procedure was repeated three times
at separated anatomical sites within the chest
wall to ensure consistency of the results. (See
‘Enhanced Content’ link below abstract for
video demonstration of procedure.)
Compliance with Ethics Guidelines
All institutional and national guidelines for the
care anduse of laboratory animalswere followed.
RESULTS
On gross observation, we found that tissue
penetration with the device in its closed
configuration was carried out easily,
overcoming tissue resistance. Expanding the
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device to its open configuration did not require
outstanding force and was done smoothly using
one hand. The device did not collapse back to
its closed configuration, and its hinges resisted
the tissue recoil without any problems.
Insertion of the silicone tube through the
device into the pleural space was easily
performed. We did not encounter any
significant bleeding or damage to adjacent
internal organs.







Fig. 2 Front view showing the ThoraXS insertion tech-
nique. The device is inserted through the chest wall in its
closed conﬁguration (a) and is then activated to change to
its open conﬁguration, thereby creating a portal for the
insertion of a chest tube (b). A silicone tube is then
positioned (c), and the device is removed, leaving the chest
tube in place (d)
Fig. 3 An in vivo pilot experiment on a swine model
Photo: Dr. Ariel Drori
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DISCUSSION
In an injured patient, chest tube insertionmay be
lifesaving. It facilitates the evacuation of fluids,
prevents the development of tension
pneumothorax or tamponades and promotes
lung re-expansion while improving respiratory
function [7]. In civilian trauma practice, the
American College of Surgeons recommends
needle decompression of tension
pneumothoraces at the second intercostal space
in the midclavicular line during the primary
survey. This should be immediately followed by
formal chest tube placement, with placement of a
large-bore catheter [8]. However, the use of this
approach seems to have developed in the absence
of a sound evidence base for efficacy and was
probably advocated and has been used widely
because of ease of access. This approach is
time-consuming, requires training and expertise
and has a high failure rate, both inside and
outside of the hospital setting [9, 10]. An
alternative approach beyond the conventional
one is definitely needed. The ThoraXS device was
designed to provide a safer, blade-free, rapid and
easy-to-use method for chest tube insertion, and
webelieve it has the potential to revolutionize the
way chest trauma patients are managed. Patients
with an indication for chest tube placement
present in several ways—while some have clear
clinical indications for immediate chest tube
insertion (respiratory or hemodynamic
instability/penetrating chest wound injury),
others present with a degree of stability that
allows the physician to seek optimal conditions.
The use of the ThoraXS device, if proven effective,
would potentially facilitate pre-hospital
treatment of tension pneumothorax, replacing
the ineffective needle decompression method.
Moreover, the ThoraXS device may impact the
threshold for intervention towards pre-hospital
chest tubeplacement even inmore stable patients
that bear a clear indication for chest tube. It may
alsoprove tobeefficacious for themanagementof
different pathologies as it can be easily positioned
facing the lung apex for ideal drainage of air (in
case of pneumothorax) or otherwise facing the
lung base for a more effective drainage of blood
(in case of hemothorax). Its unique structure and
mechanism of action makes it easy to apply to
patients of different body sizes and ages (pediatric
and adults).
Our clinical experience with the device is
still limited, and essential information on the
operating characteristics and reliability of the
device are yet to be determined. Nevertheless,
our main aim at the current stage of
development is proof of concept. Further
experiments and clinical trials are required to
support the superiority of the ThoraXS device
over conventional chest tube insertion in terms
of safety and efficacy. Similar to the
conventional chest tube insertion technique,
use of the ThoraXS device carries a potential risk
of injuring intercostal and intrathoracic
vasculature, as well as internal organs in the
chest or abdomen. It is essential that medical
teams receive proper training that focuses on
general peri-procedural, operative, and
safety-oriented aspects before attempting to
use the device.
The device is currently in its final design and
development stage. Our next step is to conduct
a larger-scale pre-clinical trial in an animal
model, and then proceed to a clinical trial.
The safety profile, efficacy and healthcare
economic benefit remain to be demonstrated.
CONCLUSIONS
As chest tube insertion in pre-hospital setting
can be challenging, we believe that the ThoraXS
device has the potential to change the way we
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treat trauma victims today, ensuring that every
chest trauma patient will receive the
appropriate treatment in a timely manner,
prior to his arrival to a medical center.
ACKNOWLEDGMENTS
No funding or sponsorship was received for this
study or publication of this article. All named
authors meet the International Committee of
Medical Journal Editors (ICMJE) criteria for
authorship for this manuscript, take
responsibility for the integrity of the work as a
whole and have given final approval for the
version to be published.
Disclosures. Ariel Drori is the founder of
ThoraXS, which develops a device for the
treatment of pneumothorax (patent pending).
Chen Goldstein is employed by ThoraXS, Yoav
Kan-tor, Bettine Nadorp, Amnon Buxboim,
Yaakov Nahmias and Liran Levy declare no
conflict of interest.
Compliance with Ethics Guidelines. All
institutional and national guidelines for the
care and use of laboratory animals were
followed.
Open Access. This article is distributed
under the terms of the Creative Commons
Attribution-NonCommercial 4.0 International
License (http://creativecommons.org/licenses/
by-nc/4.0/), which permits any noncommercial
use, distribution, and reproduction in any
medium, provided you give appropriate credit to
the original author(s) and the source, provide a
link to the Creative Commons license, and
indicate if changes were made.
REFERENCES
1. Zardo P, Busk H, Kutschka I. Chest tube
management: state of the art. Curr Opin
Anaesthesiol. 2015;28(1):45–9.
2. Havelock T, Teoh R, Laws D, Gleeson F, Group
BTSPDG. Pleural procedures and thoracic
ultrasound: British Thoracic Society Pleural
Disease Guideline 2010. Thorax. 2010;65[2]:
ii61–76.
3. Centers for Disease Control and Prevention
NCfIPaC. Web–based Injury Statistics Query and
Reporting System (WISQARS). Available at: http://
www.cdc.gov/injury/wisqars. Accessed 22 May
2016.
4. Mancini MC. Blunt chest trauma. Available at:
http://emedicine.medscape.com/article/428723-
overview. Accessed 22 May 2016.
5. Wernick B, Hon HH, Mubang RN, et al.
Complications of needle thoracostomy: A
comprehensive clinical review. Int J Crit Illn Inj
Sci. 2015;5(3):160–9.
6. Leigh-Smith S, Harris T. Tension pneumothorax—
time for a re-think? Emerg Med J. 2005;22(1):8–16.
7. Kwiatt M, Tarbox A, Seamon MJ, et al.
Thoracostomy tubes: a comprehensive review of
complications and related topics. Int J Crit Illn Inj
Sci. 2014;4(2):143–55.
8. Beckett A, Savage E, Pannell D, Acharya S,
Kirkpatrick A, Tien HC. Needle decompression for
tension pneumothorax in Tactical Combat
Casualty Care: do catheters placed in the
midaxillary line kink more often than those in the
midclavicular line? J Trauma. 2011;71[5 Suppl
1]:S408–12.
9. Waydhas C, Sauerland S. Pre-hospital pleural
decompression and chest tube placement after
blunt trauma: a systematic review. Resuscitation.
2007;72(1):11–25.
10. Harris A, O’Driscoll BR, Turkington PM. Survey of
major complications of intercostal chest drain
insertion in the UK. Postgrad Med J. 1012;
2010(86):68–72.
Pulm Ther (2016) 2:215–219 219
